Alcon Inc. (LON:0A0D)

Market Cap	28.99B -13.7%
Revenue (ttm)	7.58B +4.3%
Net Income	778.91M -9.8%
EPS	1.56 -10.2%
Shares Out	n/a
PE Ratio	37.22
Forward PE	24.45
Dividend	0.25 (0.40%)
Ex-Dividend Date	May 13, 2025

Volume	259,248
Average Volume	352,406
Open	61.87
Previous Close	61.85
Day's Range	61.86 - 62.92
52-Week Range	57.70 - 86.98
Beta	0.69
RSI	46.50
Earnings Date	Feb 24, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A0D

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD